Cargando…
What Can RNA-Based Therapy Do for Monogenic Diseases?
The use of RNA-based approaches to treat monogenic diseases (i.e., hereditary disorders caused by mutations in single genes) has been developed on different fronts. One approach uses small antisense oligonucleotides (ASOs) to modulate RNA processing at various stages; namely, to enhance correct spli...
Autores principales: | Clarke, Luka A., Amaral, Margarida D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863139/ https://www.ncbi.nlm.nih.gov/pubmed/36678889 http://dx.doi.org/10.3390/pharmaceutics15010260 |
Ejemplares similares
-
RNA Processing and mRNA Surveillance in Monogenic Diabetes
por: Locke, Jonathan M., et al.
Publicado: (2008) -
Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies
por: Guerrini, Renzo, et al.
Publicado: (2021) -
Monogenic hypertension
por: Precone, Vincenza, et al.
Publicado: (2019) -
Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019) -
Gene Therapies for Monogenic Autism Spectrum Disorders
por: Weuring, Wout, et al.
Publicado: (2021)